RGGI yields 2000000.00% · PFE yields 6.13%● Live data
📍 RGGI pulled ahead of the other in Year 1
Combined, RGGI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGGI + PFE for your $10,000?
Resgreen Group International Inc. primarily engages in the acquisition, exploration, and development of uranium mining properties in Africa. The company holds an option to acquire up to a 100% undivided right, title, and interest in and to the Gambaro Resources property located in Njombe and Songea districts in the Republic of Tanzania. It also has option to acquire up to a 75% undivided right, title, and interest in and to the Nkoko and Kagadi uranium properties, which contain approximately 820 square kilometers located in Kiballe District, Uganda; and option to earn a 75% interest in the Karoo project that consists of approximately 8,600 square kilometers of Karoo-based uranium exploration lands located in the Southern regions of Tanzania. The company was formerly known as Uranium Hunter Corporation and changed its name to Resgreen Group International Inc. in February 2007. Resgreen Group International Inc. was founded in 2003 and is based in Toronto, Canada.
Full RGGI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.